Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors?
| Image |  |
|---|---|
| Description | scientific article published on 14 November 2019 |
| Author/s |
author: Luis Furuya-Kanamori |
| Publication date | November 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |